Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Conventional scale-up rules of thumb, such as constant power per volume, fail to accurately reproduce cellular microenvironments when working with shear-sensitive cell therapies or delicate organisms like Streptomyces. By simulating and matching comprehensive physical parameters across vessels using CFD, teams achieve far more comparable cell morphology and reliable cell growth without relying on protective additives like antifoam.

Related Insights

Scaling up a bioprocess from lab to production fundamentally alters physical properties like oxygen transfer (KLA). This change in physics, not necessarily a procedural mistake, is often the root cause of failure at scale, leading to different cell growth and product quality.

Instead of waiting for physical tech transfer runs, biotech startups can use CFD to determine whether a process refined in micro-bioreactors will run safely in a CDMO's specific reactor fleet. Performing this virtual scale-up in advance derisks facility selection, reduces timeline and financial commitments, and provides verifiable technical proof for prospective investors.

Because CFD operates strictly on physical parameters rather than biological mechanisms, a vessel needs to be fully characterized only once across 100 to 200 operational points. When switching to a new molecule, media, or cell line, the scale-up software only needs updated fluid properties such as viscosity, density, surface tension, and salt concentration, eliminating the need to re-run simulations from scratch.

To handle delicate primary cells, Ori Biotech designed a single bellows-based bioreactor that operates in multiple modes: static (T-flask), rocked (wave reactor), or with low-shear plunging (stirred tank). This flexibility allows optimization of different process steps like activation, transduction, and expansion within the same container.

New modalities like CAR-T and cultivated meat are highly shear-sensitive. Shaken bioreactors are ideal because they are surface-aerated, avoiding bubble formation. The primary cause of cell damage is not the mixing itself, but the high local shear forces created when bubbles burst, a problem that surface aeration circumvents.

Scaling from a T-flask to a bioreactor isn't just increasing volume; it's a fundamental shift in the biological context. Changes in cell density, mass transfer, and mechanical stress rewire cell signaling. Therefore, understanding and respecting the cell's biology must be the primary design input for successful scale-up.

For live cell therapies, the manufacturing process fundamentally shapes the biological product. Teams often rush to scale production, focusing on yield and cost. Instead, they should first fully understand how the process impacts cell potency and function to avoid effectively scaling the wrong biology.

The challenge of scaling 3D cell cultures isn't just about building larger systems. A more fundamental problem is the inability to measure and characterize the complex 3D environment in real-time. Without effective in-process analytics to ensure quality control and process optimization, true industrial scalability remains unachievable.

Scaling from shake flasks to stirred-tank reactors is notoriously difficult because flasks feature violent surface rotation and thin liquid wall films. The free-surface algorithms originally developed to track large rising gas bubbles in 160,000-liter reactors can accurately model oxygen transfer and shear in shake flasks, allowing direct mathematical translation into stirred-tank aeration and agitation parameters.

There's no universal bioreactor setting for 3D tissue models. Each tissue type has unique biological needs. For instance, neural cells require minimal shear stress and low oxygen, whereas liver cells need rigorous perfusion flow to maintain metabolic competence, mandating highly tailored process design for each model.

Traditional Power-Per-Volume Scale-Up Fails to Preserve Cell Morphology in Sensitive Cultures | RiffOn